Integrated DNA Technologies launches rapid genes and significant upgrades to gene synthesis offerings

Aug. 7, 2024
Expanded gene offerings include new vector options, transparent pricing and expedited turnaround times.

Integrated DNA Technologies (IDT) released rapid genes, a new offering in its synthetic biology portfolio.

Available from 125 base pairs (bp) to 2000 bp, IDT’s rapid genes are ready-to-use, next generation sequencing (NGS)-verified clonal genes shipped in as little as five business days. Rapid genes are priced at $0.15 USD per bp and delivered in a plate format for automated workflows.

Rapid genes are circular double-stranded DNA in a plasmid and are available to ship dry or in a resuspension buffer in 96-well or 384-well plates. In addition to rapid genes, IDT is also rolling out enhancements to its existing gene synthesis offerings, including additional standard bacterial and mammalian expression vectors, expanded yield up to 100 µg with endotoxin free option.

IDT release

ID 215927108 © Hulko Svitlana | Dreamstime.com
dreamstime_xxl_215927108
ID 61156402 © Vitaliy Smolygin | Dreamstime.com
dreamstime_xxl_61156402
By Tahsin on Adobe Stock
adobestock_919184766
ID 141702959 © Ustyna Shevhcuk | Dreamstime.com
dreamstime_xxl_141702959